Project Title: |
Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN (NOBLE) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
This is a Phase 2, multicenter, open-label, randomized, controlled study designed to evaluate the safety and efficacy of pegcetacoplan in patients who have post-transplant recurrence of C3G or IC-MPGN. |
Lead principal investigator(s): |
,
|
Co-investigator(s): |
Erica Daina, Bergamo
|
Project Period: |
09/2021 - 11/2023 |